These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18162522)

  • 1. An intracellular loop (IL2) residue confers different basal constitutive activities to the human lutropin receptor and human thyrotropin receptor through structural communication between IL2 and helix 6, via helix 3.
    Feng X; Müller T; Mizrachi D; Fanelli F; Segaloff DL
    Endocrinology; 2008 Apr; 149(4):1705-17. PubMed ID: 18162522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor.
    Zhang M; Mizrachi D; Fanelli F; Segaloff DL
    J Biol Chem; 2005 Jul; 280(28):26169-76. PubMed ID: 15908694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor.
    Shinozaki H; Butnev V; Tao YX; Ang KL; Conti M; Segaloff DL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1194-204. PubMed ID: 12629106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization.
    Zhang M; Feng X; Guan R; Hébert TE; Segaloff DL
    Cell Signal; 2009 Nov; 21(11):1663-71. PubMed ID: 19616090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
    Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
    Latronico AC; Shinozaki H; Guerra G; Pereira MA; Lemos Marini SH; Baptista MT; Arnhold IJ; Fanelli F; Mendonca BB; Segaloff DL
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4799-805. PubMed ID: 11134146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.
    Latronico AC; Segaloff DL
    Mol Cell Endocrinol; 2007 Jan; 260-262():287-93. PubMed ID: 17055147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation.
    Galet C; Ascoli M
    Mol Endocrinol; 2006 Nov; 20(11):2931-45. PubMed ID: 16803865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty.
    Latronico AC; Abell AN; Arnhold IJ; Liu X; Lins TS; Brito VN; Billerbeck AE; Segaloff DL; Mendonca BB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2435-40. PubMed ID: 9661624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs.
    Abell AN; McCormick DJ; Segaloff DL
    Mol Endocrinol; 1998 Dec; 12(12):1857-69. PubMed ID: 9849960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor.
    Tao YX; Johnson NB; Segaloff DL
    J Biol Chem; 2004 Feb; 279(7):5904-14. PubMed ID: 14594799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III.
    Tao YX; Abell AN; Liu X; Nakamura K; Segaloff DL
    Mol Endocrinol; 2000 Aug; 14(8):1272-82. PubMed ID: 10935550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty.
    Laue L; Wu SM; Kudo M; Hsueh AJ; Cutler GB; Jelly DH; Diamond FB; Chan WY
    Biochem Mol Med; 1996 Aug; 58(2):192-8. PubMed ID: 8812739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activity of the lutropin receptor and its allosteric modulation by receptor heterodimerization.
    Segaloff DL
    Methods Enzymol; 2010; 484():231-52. PubMed ID: 21036235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between lutropin-mediated and choriogonadotropin-mediated receptor activation.
    Grzesik P; Teichmann A; Furkert J; Rutz C; Wiesner B; Kleinau G; Schülein R; Gromoll J; Krause G
    FEBS J; 2014 Mar; 281(5):1479-1492. PubMed ID: 24438591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides.
    Morris JC; Bergert ER; McCormick DJ
    J Biol Chem; 1993 May; 268(15):10900-5. PubMed ID: 8496155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GIPC binds to the human lutropin receptor (hLHR) through an unusual PDZ domain binding motif, and it regulates the sorting of the internalized human choriogonadotropin and the density of cell surface hLHR.
    Hirakawa T; Galet C; Kishi M; Ascoli M
    J Biol Chem; 2003 Dec; 278(49):49348-57. PubMed ID: 14507927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations.
    Zhang M; Tao YX; Ryan GL; Feng X; Fanelli F; Segaloff DL
    J Biol Chem; 2007 Aug; 282(35):25527-39. PubMed ID: 17609213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function.
    Jaeschke H; Neumann S; Kleinau G; Mueller S; Claus M; Krause G; Paschke R
    Endocrinology; 2006 Apr; 147(4):1753-60. PubMed ID: 16410307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding.
    Haraguchi K; Saito T; Endo T; Onaya T
    Life Sci; 1994; 55(12):961-8. PubMed ID: 7914657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.